Today's Research Reports on Trending Tickers: Ionis Pharmaceuticals and Juno Therapeutics
NEW YORK, NY / ACCESSWIRE / August 9, 2017 / The market's recent rally stalled Tuesday as early gains were wiped out after President Donald Trump warned North Korea that any threats will be "met with fire and fury." The Dow Jones Industrial Average declined 0.15 percent to close at 22,085.34, breaking its streak of nine consecutive record closes, while the S&P 500 Index fell 0.24 percent to close at 2,474.92. The NASDAQ Composite Index declined 0.21 percent to close at 6,370.46. The CBOE Volatility Index, a key measure of market expectations of near-term volatility conveyed by S&P 500 stock index option prices, spiked almost 11 percent to close at 10.96.
"The geopolitical tensions could be the catalyst for the market's direction in the next coming weeks depending on how it all shakes out," said Robert Pavlik, Chief Investment Strategist at Boston Private. "If those talks keep escalating, the market will get nervous."
RDI Initiates Coverage on:
Ionis Pharmaceuticals Inc.
https://ub.rdinvesting.com/news/?ticker=IONS
Juno Therapeutics Inc.
https://ub.rdinvesting.com/news/?ticker=JUNO
Ionis Pharmaceuticals Inc.'s stock moved 8.09% lower Tuesday, to close the day at $48.31. The stock recorded a trading volume of 2,750,997 shares, which was above its three months average volume of 1,419,600 shares. In the last year, Ionis Pharmaceuticals Inc.'s shares have traded in a range of 24.58 - 60.01. The share price has gained 96.54% from its 52 week low. The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $53.06 is greater than its 200-day moving average of $46.75. Shares of Ionis Pharmaceuticals have gained approximately 1 percent year-to-date.
Access RDI's Ionis Pharmaceuticals Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=IONS
On Tuesday, shares in Juno Therapeutics Inc. recorded a trading volume of 1,214,115 shares, which was below the three months average volume of 1,908,850 shares. The stock ended the day 4.90% lower at 28.90. The share price has gained 64.95% from its 52 week low with a 52 week trading range of 17.52 - 35.04.The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $28.51 is greater than its 200-day moving average of $24.26. Shares of Juno Therapeutics have gained approximately 53.32 percent year-to-date.
Access RDI's Juno Therapeutics Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=JUNO
Our Actionable Research on Ionis Pharmaceuticals Inc. (NASDAQ: IONS) and Juno Therapeutics Inc. (NASDAQ: JUNO) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
